China treats tens of thousands of its citizens with experimental coronavirus vaccines that have not been tested, leading to protection concerns.
In July, China introduced an emergency vaccine program that provides 3 experimental injections developed through a unit of state-owned pharmaceutical company China National Pharmaceutical Group (Sinopharm) and biopharmaceutical company Sinovac Biotech.
The vaccines were designed for the essential workers, adding those in the medical, transportation and grocery industry sectors.
But now, China National Biotec Group, The Sinopharm unit that presents two of the emergency vaccines, and Sinovac Biotech have shown that at least tens of thousands of others have been trapped through unproven vaccines.
The expert leader in the prevention of biotechnological threats at the Center for Disease Control and Prevention in the country among which they were temporarily vaccinated.
“So far, among the other people who have been vaccinated, no one has had the disease,” Guizhen Wu said on state television this week, while revealing that he won the vaccination in April.
“So far, [the immunization program] is working very well. There were no effects. “
A fourth COVID-19 vaccine developed through CanSino Biologics was also approved for use through the Chinese army in June.
At least some of the vaccines would be in a position to be used by the public in November, Wu said.
Meanwhile, experts in Western countries have warned that they oppose mild ecology for emergency use of vaccines that have finished testing due to a lack of wisdom about long-term efficacy and possible side effects.
Anna Durbin, vaccine researcher at Johns Hopkins University, China’s “very problematic” emergency use program.
“Vaccinate other people and you don’t know if they will,” Durbin told Reuters.
Russia is one of the few countries that allows the use of an experimental vaccine, which makes its own “Sputnik V” vaccine mandatory for certain groups, teachers added.
And this week, the United Arab Emirates legalized the emergency use of a Sinopharm vaccine, in the first foreign emergency authorization for one of China’s vaccines.
Tens of thousands of people in China get experimental vaccines opposed to COVID-19 Wire Services/New York Post.